-The Hindu Business Line It’s only an open-ended deal with co-developer Bharat Biotech, says top source The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended. Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR’s Pune-based National Institute of Virology...

-Hindustan Times A rapid and universal vaccination programme is essential to control a surge of this magnitude and time is of the essence — for the virus is not standing still The second wave of Covid-19 is overwhelming India. The official death toll is already inching towards 250,000, but this is almost surely a vast underestimate, as the virus sweeps through rural India and kills many whose deaths will never be captured...

-The Indian Express A waiver on IP protections would mean pharmaceutical firms and vaccine makers across the world can learn how to make these vaccines without fear of lawsuits from companies that originally developed them. In a move that could potentially help increase production of Covid-19 vaccines around the world, the United States on Wednesday announced its support for waiving intellectual property (IP) protections for these vaccines. Subsequently, the European Union (EU) agreed...

-The Hindu The news will support the increased production of vaccines globally as countries, including India, continue to reel under the impact of the pandemic. The United States will support an initiative at the World Trade Organisation (WTO) to waive Trade Related Intellectual Property Rights (TRIPS) protection for COVID-19 vaccines, the Biden administration said on Wednesday. The news will support the increased production of vaccines globally as countries, including India, continue to...

-The Hindu 12 Republican lawmakers write a seven-page letter to U.S. Trade Representative Katherine Tai on the issue U.S. President Joe Biden said on Tuesday that he had not made a decision on whether the U.S. would support an Indian and South African initiative at the World Trade Organisation (WTO) to waive Trade Related Intellectual Property Rights (TRIPS) to facilitate the production of COVID-19 related vaccines and therapeutics around the world. “Well, we’re...